The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Open accessAbstract
Background Patients with COVID-19 pneumonia have an excess of inflammation and increased concentrations of cytokines including interleukin-1 (IL-1). We aimed to determine whether anakinra, a recombinant human IL-1 receptor antagonist, could improve outcomes in patients in hospital with mild-to-moderate COVID-19 pneumonia. Methods In this multicentre, open-label, Bayesian randomised clinical trial (CORIMUNO-ANA-1), nested within the CORIMUNO-19 cohort, we recruited patients from 16 University hospitals in France with mild-to-moderate COVID-19 pneumonia, severe acute respiratory syndrome coronavirus 2 infection confirmed by real-time RT-PCR, requiring at least 3 L/min of oxygen by mask or nasal cannula but without ventilation assistance, a score of 5 on the WHO Clinical Progression Scale (WHO-CPS), and a C-reactive protein serum concentration of more than 25 mg/L not requiring admission to the intensive care unit at admission to hospital. Eligible patients were randomly assigned (1:1) using a web-based secure centralised system, stratified by centre and blocked with varying block sizes (randomly of size two or four), to either usual care plus anakinra (200 mg twice a day on days 1–3, 100 mg twice on day 4, 100 mg once on day 5) or usual care alone. Usual care was provided at the discretion of the site clinicians. The two coprimary outcomes were the proportion of patients who had died or needed non-invasive or mechanical ventilation by day 4 (ie, a score of >5 on the WHO-CPS) and survival without need for mechanical or non-invasive ventilation (including high-flow oxygen) at day 14. All analyses were done on an intention-to-treat basis. The trial is registered with ClinicalTrials.gov, NCT04341584, and is now closed to accrual. Findings Between April 8 and April 26, 2020, we screened 153 patients. The study was stopped early following the recommendation of the data and safety monitoring board, after the recruitment of 116 patients: 59 were assigned to the anakinra group, and 57 were assigned to the usual care group. Two patients in the usual care group withdrew consent and were not analysed. In the analysable population, the median age was 66 years (IQR 59 to 76) and 80 (70%) participants were men. In the anakinra group, 21 (36%) of 59 patients had a WHO-CPS score of more than 5 at day 4 versus 21 (38%) of 55 in the usual care group (median posterior absolute risk difference [ARD] −2·5%, 90% credible interval [CrI] −17·1 to 12·0), with a posterior probability of ARD of less than 0 (ie, anakinra better than usual care) of 61·2%. At day 14, 28 (47%; 95% CI 33 to 59) patients in the anakinra group and 28 (51%; 95% CI 36 to 62) in the usual care group needed ventilation or died, with a posterior probability of any efficacy of anakinra (hazard ratio [HR] being less than 1) of 54·5% (median posterior HR 0·97; 90% CrI 0·62 to 1·52). At day 90, 16 (27%) patients in the anakinra group and 15 (27%) in the usual care group had died. Serious adverse events occurred in 27 (46%) patients in the anakinra group and 21 (38%) in the usual care group (p=0·45). Interpretation Anakinra did not improve outcomes in patients with mild-to-moderate COVID-19 pneumonia. Further studies are needed to assess the efficacy of anakinra in other selected groups of patients with more severe COVID-19. Funding The Ministry of Health, Programme Hospitalier de Recherche Clinique, Foundation for Medical Research, and AP-HP Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
Cited by
Drug treatments for covid-19: living systematic review and network meta-analysis
Siemieniuk, R. A., Bartoszko, J. J., Zeraatkar, D., Kum, E., Qasim, A., Díaz Martinez, J. P., Izcovich, A., Rochwerg, B., Lamontagne, F., Han, M. A., et al. (2020) · BMJ · doi:10.1136/bmj.m2980 · Cited by 846
Innate immunity: the first line of defense against SARS-CoV-2
Diamond, M. S., & Kanneganti, T.-D. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 618
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Kyriazopoulou, E., Poulakou, G., Milionis, H., Metallidis, S., Adamis, G., Tsiakos, K., Fragkou, A., Rapti, A., Damoulari, C., Fantoni, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01499-z · Cited by 536
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Guimarães, P. O., Quirk, D., Furtado, R. H., Maia, L. N., Saraiva, J. F., Antunes, M. O., Kalil Filho, R., Junior, V. M., Soeiro, A. M., Tognon, A. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101643 · Cited by 435
Metadata
- Authors
- Tharaux, P.-L., Pialoux, G., Pavot, A., Mariette, X., Hermine, O., Resche-Rigon, M., Porcher, R., Ravaud, P., Bureau, S., Dougados, M., Tibi, A., Azoulay, E., Cadranel, J., Emmerich, J., Fartoukh, M., Guidet, B., Humbert, M., Lacombe, K., Mahevas, M., Pene, F., Pourchet-Martinez, V., Schlemmer, F., Yazdanpanah, Y., Baron, G., Perrodeau, E., Vanhoye, D., Kedzia, C., Demerville, L., Gysembergh-Houal, A., Bourgoin, A., Dalibey, S., Raked, N., Mameri, L., Alary, S., Hamiria, S., Bariz, T., Semri, H., Hai, D. M., Benafla, M., Belloul, M., Vauboin, P., Flamand, S., Pacheco, C., Walter-Petrich, A., Stan, E., Benarab, S., Nyanou, C., Montlahuc, C., Biard, L., Charreteur, R., Dupré, C., Cardet, K., Lehmann, B., Baghli, K., Madelaine, C., D'Ortenzio, E., Puéchal, O., Semaille, C., Savale, L., Harrois, A., Figueiredo, S., Duranteau, J., Anguel, N., Monnet, X., Richard, C., Teboul, J.-L., Durand, P., Tissieres, P., Jevnikar, M., Montani, D., Bulifon, S., Jaïs, X., Sitbon, O., Pavy, S., Noel, N., Lambotte, O., Escaut, L., Jauréguiberry, S., Baudry, E., Verny, C., Noaillon, M., Lefèvre, E., Zaidan, M., Le Tiec, C. L. T., Verstuyft, C. V., Roques, A.-M., Grimaldi, L., Molinari, D., Leprun, G., Fourreau, A., Cylly, L., Virlouvet, M., Meftali, R., Fabre, S., Licois, M., Mamoune, A., Boudali, Y., Georgin-Lavialle, S., Senet, P., Soria, A., Parrot, A., François, H., Rozensztajn, N., Blin, E., Choinier, P., Camuset, J., Rech, J.-S., Canellas, A., Rolland-Debord, C., Lemarié, N., Belaube, N., Nadal, M., Siguier, M., Petit-Hoang, C., Chas, J., Drouet, E., Lemoine, M., Phibel, A., Aunay, L., Bertrand, E., Ravato, S., Vayssettes, M., Adda, A., Wilpotte, C., Thibaut, P., Fillon, J., Debrix, I., Fellahi, S., Bastard, J.-P., Lefèvre, G., Fallet, V., Gottenberg, J.-E., Hansmann, Y., Andres, E., Bayer, S., Becker, G., Blanc, F., Brin, S., Castelain, V., Chatelus, E., Chatron, E., Collange, O., Danion, F., De Blay, F., Demonsant, E., Diemunsch, P., Diemunsch, S., Felten, R., Goichot, B., Greigert, V., Guffroy, A., Heger, B., Hutt, A., Kaeuffer, C., Kassegne, L., Korganow, A. S., Le Borgne, P., Lefebvre, N., Martin, T., Mertes, P. M., Metzger, C., Meyer, N., Nisand, G., Noll, E., Oberlin, M., Ohlmann-Caillard, S., Poindron, V., Pottecher, J., Ruch, Y., Sublon, C., Tayebi, H., Weill, F., Mekinian, A., Chopin, D., Fain, O., Garnier, M., Krause le Garrec, J., Morgand, M., Pacanowski, J., Urbina, T., McAvoy, C., Pereira, M., Aratus, G., Berard, L., Simon, T., Daguenel-Nguyen, A., Antignac, M., Leplay, C., Arlet, J.-B., Diehl, J.-L., Bellenfant, F., Blanchard, A., Buffet, A., Cholley, B., Fayol, A., Flamarion, E., Godier, A., Gorget, T., Hamada, S.-R., Hauw-Berlemont, C., Hulot, J.-S., Lebeaux, D., Livrozet, M., Michon, A., Neuschwander, A., Penet, M.-A., Planquette, B., Ranque, B., Sanchez, O., Volle, G., Briois, S., Cornic, M., Elisee, V., Jesuthasan, D., Djadi-Prat, J., Jouany, P., Junquera, R., Henriques, M., Kebir, A., Lehir, I., Meunier, J., Patin, F., Paquet, V., Tréhan, A., Vigna, V., Sabatier, B., Bergerot, D., Jouve, C., Knosp, C., Lenoir, O., Mahtal, N., Resmini, L., Lescure, F.-X., Ghosn, J., BACHELARD, A., BIRONNE, T., BORIE, R., BOUNHIOL, A., BOUSSARD, C., CHAUFFiER, J., CHALAL, S., CHALAL, L., CHANSOMBAT, M., CRESPIN, P., CRESTANI, B., DACONCEICAO, O., DECONINCK, L., DIEUDE, P., DOSSIER, A., DUBERT, M., DUCROCQ, G., FUENTES, A., GERVAIS, A., GILBERT, M., ISERNIA, V., ISMAEL, S., JOLY, V., JULIA, Z., LARIVEN, S., LE GAC, S., LE PLUART, D., LOUNI, F., NDIAYE, A., PAPO, T., PARISEY, M., PHUNG, B., POURBAIX, A., RACHLINE, A., RIOUX, C., SAUTEREAU, A., STEG, G., TARHINI, H., VALAYER, S., VALLOIS, D., VERMES, P., VOLPE, T., Nguyen, Y., Honsel, V., Weiss, E., Codorniu, A., Zarrouk, V., De Lastours, V., Uzzan, M., Olivier, O., Rossi, G., Gamany, N., Rahli, R., Louis, Z., Boutboul, D., Galicier, L., Amara, Y., Archer, G., Benattia, A., Bergeron, A., Bondeelle, L., De Castro, N., Clément, M., Darmont, M., Denis, B., Dupin, C., Feredj, E., Feyeux, D., Joseph, A., Lengliné, E., Le Guen, P., Liégeon, G., Lorillon, G., Mabrouki, A., Mariotte, E., Martin de Frémont, G., Mirouse, A., Molina, J.-M., Peffault de Latour, R., Oksenhendler, E., Saussereau, J., Tazi, A., Tudesq, J.-J., Zafrani, L., Brindele, I., Bugnet, E., Celli Lebras, K., Chabert, J., Djaghout, L., Fauvaux, C., Jegu, A. L., Kozaliewicz, E., Meunier, M., Tremorin, M.-T., Davoine, C., Madeleine, I., Caillat-Zucman, S., Delaugerre, C., Morin, F., SENE, D., BURLACU, R., CHOUSTERMAN, B., MEGARBANE, B., RICHETTE, P., RIVELINE, J.-P., FRAZIER, A., VICAUT, E., BERTON, L., HADJAM, T., VASQUEZ-IBARRA, M. A., JOURDAINE, C., JACOB, A., SMATI, J., RENAUD, S., MANIVET, P., PERNIN, C., SUAREZ, L., Semerano, L., ABAD, S., Benainous, R., Bloch Queyrat, C., Bonnet, N., Brahmi, S., Cailhol, J., Cohen, Y., Comparon, C., Cordel, H., Dhote, R., Dournon, N., Duchemann, B., Ebstein, N., Giroux-Leprieur, B., Goupil de Bouille, J., Jacolot, A., Nunes, H., Oziel, J., Rathouin, V., Rigal, M., Roulot, D., Tantet, C., Uzunhan, Y., COSTEDOAT-CHALUMEAU, N., Ait Hamou, Z., Benghanem, S., BLANCHE, P., CANOUI, E., CARLIER, N., CHAIGNE, B., CONTEJEAN, A., DUNOGUE, B., DUPLAND, P., DUREL - MAURISSE, A., GAUZIT, R., JAUBERT, P., Joumaa, H., Jozwiak, M., KERNEIS, S., LACHATRE, M., Lafoeste, H., LEGENDRE, P., LUONG NGUYEN, L. B., MAREY, J., MORBIEU, C., MOUTHON, L., NGUYEN, L., Palmieri, L.-J., REGENT, A., SZWEBEL, T.-A., TERRIER, B., GUERIN, C., ZERBIT, J., CHEREF, K., CHITOUR, K., CISSE, M. S., CLARKE, A., CLAVERE, G., DUSANTER, I., GAUDEFROY, C., JALLOULI, M., KOLTA, S., LE BOURLOUT, C., MARIN, N., MENAGE, N., MOORES, A., PEIGNEY, I., PIERRON, C., SALEH-MGHIR, S., VALLET, M., MICHEL, M., MELICA, G., LELIEVRE, J.-D., FOIS, E., LIM, P., MATIGNON, M., GUILLAUD, C., THIEMELE, A., SCHMITZ, D., BOUHRIS, M., BELAZOUZ, S., LANGUILLE, L., MEKONTSO-DESSAPS, A., SADAOUI, T., Mayaux, J., Cacoub, P., Corvol, J.-C., Louapre, C., Sambin, S., Mariani, L.-L., Karachi, C., Tubach, F., Estellat, C., Gimeno, L., Martin, K., Bah, A., Keo, V., Ouamri, S., Messaoudi, Y., Yelles, N., Faye, P., Cavelot, S., Larcheveque, C., Annonay, L., Benhida, J., Zahrate-Ghoul, A., Hammal, S., Belilita, R., Lecronier, M., Beurton, A., Haudebourg, L., Deleris, R., Le Marec, J., Virolle, S., Nemlaghi, S., Bureau, C., Mora, P., De Sarcus, M., Clovet, O., Duceau, B., Grisot, P. H., Pari, M. H., Arzoine, J., Clarac, U., Faure, M., Delemazure, J., Decavele, M., Morawiec, E., Demoule, A., Dres, M., Vautier, M., Allenbach, Y., Benveniste, O., Leroux, G., Rigolet, A., Guillaume-Jugnot, P., Domont, F., Desbois, A. C., Comarmond, C., Champtiaux, N., Toquet, S., Ghembaza, A., Vieira, M., Maalouf, G., Boleto, G., Ferfar, Y., Charbonnier, F., AGUILAR, C., ALBY-LAURENT, F., ALYANAKIAN, M.-A., BAKOUBOULA, P., BROISSAND, C., BURGER, C., CAMPOS-VEGA, C., CHAVAROT, N., CHOUPEAUX, L., FOURNIER, B., GRANVILLE, S., ISSORAT, E., ROUZAUD, C., VIMPERE, D., Geri, G., Derridj, N., Sguiouar, N., Meddah, H., Djadel, M., Chambrin-Lauvray, H., Duclos-Vallée, J.-C., Saliba, F., Sacleux, S.-C., Koumis, I., Michot, J.-M., Stoclin, A., Colomba, E., Pommeret, F., Willekens, C., Sakkal, M., Da Silva, R., Dejean, V., Mekid, Y., Ben-Mabrouk, I., Pradon, C., Drouard, L., Camara-Clayette, V., Morel, A., Garcia, G., Mohebbi, A., Berbour, F., Dehais, M., Pouliquen, A.-L., Klasen, A., Soyez-Herkert, L., London, J., Keroumi, Y., Guillot, E., Grailles, G., El Amine, Y., Defrancq, F., Fodil, H., Bouras, C., Dautel, D., Gambier, N., Dieye, T., Razurel, A., Bienvenu, B., Lancon, V., Lecomte, L., Beziriganyan, K., Asselate, B., Allanic, L., Kiouris, E., Legros, M.-H., Lemagner, C., Martel, P., Provitolo, V., Ackermann, F., Le Marchand, M., Clan Hew Wai, A., Fremont, D., Coupez, E., Adda, M., Duée, F., Bernard, L., Gros, A., Henry, E., Courtin, C., Pattyn, A., Guinot, P.-G., Bardou, M., Maurer, A., Jambon, J., Cransac, A., Pernot, C., Mourvillier, B., Servettaz, A., Deslée, G., Wynckel, A., Benoit, P., Marquis, E., Roux, D., Gernez, C., Yelnik, C., Poissy, J., Nizard, M., Denies, F., Gros, H., Mourad, J.-J., Sacco, E., & Renet, S.
- Venue
- The Lancet Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 9
- Issue
- 3
- Pages
- 295-304
- ISSN
- 2213-2600 (ISSN-L)
- OpenAlex
- W3124292577
- Cited by
- 284
- References
- 23
- FWCI
- 19.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2213-2600(20)30556-7
- The paper
- Tharaux, P.-L., Pialoux, G., Pavot, A., Mariette, X., Hermine, O., Resche-Rigon, M., Porcher, R., Ravaud, P., Bureau, S., Dougados, M., Tibi, A., Azoulay, E., Cadranel, J., Emmerich, J., Fartoukh, M., Guidet, B., Humbert, M., Lacombe, K., Mahevas, M., . . . Renet, S. (2021). Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(20)30556-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.